For example, studies have revealed that tumor-repopulating cells rely on PCK2-mediated phospholipid remodeling to resist ferroptosis, while CSCs promote PCK2 ubiquitination and degradation through the STAT3/HERC6 pathway, maintaining membrane phospholipids in a ferroptosis-resistant state (Long et al., 2025). Here, PCK2 is linked to neoplasm.